Just days after Russia’s Sistema Asia Fund invested in the Indian healthcare startup Netmeds, Altair VC, a fund with Russian roots operating internationally, participated in a $5 million round for another Indian healthtech startup, DocTalk.
The deal was reported last week by the Times of India.
Led by two California-based funds — Matrix Partners and Khosla Ventures, — the round also involved DocTalk’s earlier backer Y Combinator, Dubai-based fund Vy Capital, and a number of business angels, including Paul Buchheit, the creator of Gmail.
DocTalk plans to use the fresh capital to expand its team and engage hospital chains in its platform.
“We are looking to hire across departments such as sales, operations and technology as we plan to expand into new cities. We also have to develop a deeper presence in our existing markets,” the Indian media quoted Akshat Goenka, DocTalk’s founder and CEO, as saying.
Headquartered in Mumbai, DocTalk currently operates in Delhi and Hyderabad.
The app allows doctors and patients to stay in touch and skip in-person follow-on visits. Thus the startup aims to enable doctors to plug revenue leakage and maintain relationships with patients through the entire treatment cycle.
Last month Altair VC participated in a $840,000 round for Cherry Labs, a Russian-founded AI startup. The round also involved Impulse VC, a venture fund which is reportedly affiliated to Russian billionaire Roman Abramovich, and Gagarin Capital, a US-based venture fund with Russian roots.
Source: CrunchBase, The Times of India.
